|
ZNF721 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.561200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.085200E-01 |
| Normal-vs-Stage2 |
2.452400E-01 |
| Normal-vs-Stage3 |
8.045900E-02 |
| Normal-vs-Stage4 |
1.600600E-01 |
| Stage1-vs-Stage2 |
5.796000E-01 |
| Stage1-vs-Stage3 |
5.715200E-03 |
| Stage1-vs-Stage4 |
1.304460E-02 |
| Stage2-vs-Stage3 |
3.930400E-02 |
| Stage2-vs-Stage4 |
5.874300E-02 |
| Stage3-vs-Stage4 |
8.139800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.127000E-01 |
| Normal-vs-AfricanAmerican |
9.978000E-01 |
| Normal-vs-Asian |
2.645200E-01 |
| Caucasian-vs-AfricanAmerican |
9.479400E-01 |
| Caucasian-vs-Asian |
5.260200E-01 |
| AfricanAmerican-vs-Asian |
4.831600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.579600E-01 |
| Normal-vs-Female |
6.516000E-02 |
| Male-vs-Female |
3.883800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.468800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.084200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.462000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.233400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.920420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.131200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.713800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.892200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.042200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.978020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.034300E-04 |
| Normal-vs-Grade 2 |
3.281900E-02 |
| Normal-vs-Grade 3 |
1.348220E-01 |
| Normal-vs-Grade 4 |
2.137200E-03 |
| Grade 1-vs-Grade 2 |
2.028000E-01 |
| Grade 1-vs-Grade 3 |
1.398540E-03 |
| Grade 1-vs-Grade 4 |
2.34359999999878E-05 |
| Grade 2-vs-Grade 3 |
3.188100E-04 |
| Grade 2-vs-Grade 4 |
1.15199999994875E-06 |
| Grade 3-vs-Grade 4 |
6.703900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.858300E-02 |
| Normal-vs-ccB subtype |
4.544000E-01 |
| ccA subtype-vs-ccB subtype |
4.255400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.946000E-01 |
| Normal-vs-N1 |
5.313700E-02 |
| N0-vs-N1 |
5.451500E-02 |
|
|
